Cipla to buy two U.S. generic drug firms for $550 million

04-Sep-2015 #India-US,#Healthcare & Pharma Source: Reuters
Indian pharmaceutical firm Cipla has agreed to buy two generics businesses in the United States, InvaGen Pharmaceuticals Inc and Exelan Pharmaceuticals Inc in an all-cash deals worth $550 million, as part of an effort to boost its presence in the world's largest generics market.
Read Full Article..
Tagged: ,
Array
(
    [0] => post-template-default
    [1] => single
    [2] => single-post
    [3] => postid-8016
    [4] => single-format-standard
    [5] => do-etfw
    [6] => wpb-js-composer js-comp-ver-3.6.14.1
    [7] => vc_responsive
)
8016false